Pharma & Biotech

The investment thesis for Absci (NASDAQ: ABSI) is gaining traction among Wall Street analysts, who collectively point to significant upside...

Shares of BioNTech advanced significantly on Friday following an upgrade from Goldman Sachs. The US investment bank now views the...

BioNTech is fundamentally realigning its business model, shifting focus from the extraordinary COVID-19 period to a clear strategic emphasis on...

As Abbott Laboratories prepares to release its quarterly earnings, investor focus is split between a promising new product announcement and...

Market observers are adopting a guardedly optimistic stance toward biotechnology leader Amgen. Operating in a fiercely competitive sector, the company...

Biopharmaceutical firm Anavex Life Sciences is charting a new course in Europe after a recent regulatory challenge. The company is...

Shares of Viking Therapeutics experienced a significant surge this week, driven by a series of strategic updates and a notable...

Presenting at the J.P. Morgan Healthcare Conference, Adma Biologics significantly upgraded its financial outlook, introducing detailed projections that extend to...

The publication of peer-reviewed final data from two pivotal Phase 3 trials has dealt a definitive blow to Cassava Sciences'...

The recent upward momentum for Bionxt Solutions has hit a significant obstacle. Shares in the bioscience company reversed sharply on...